Dr.Max made a net profit of CZK 762 mil in 2022, up 31.7% compared to the previous year. Total sales reached CZK 24,796 mil, which is up 9.88% when compared to the previous year.
Historically, between 2013 and 2022, the company’s net profit reached a high of CZK 828 mil in 2014 and a low of CZK -187 mil in 2015. Over the last decade the firm's net profit increased by an average of 0% a year.
Sales have grown by 0% a year on average since 2012. They reached a high of CZK 24,796 mil in 2022 and a low of CZK 12,320 mil in 2014.
The company has been operating with an average EBITDA margin of 6.17% in the last 5 years and average net margin of 2.22%. The firm generated an average return on invested capital of 4.57% for its shareholders over the last five years.
You can see all the company’s data at Dr.Max profile, or you can download a report on the company in the report section.
Helgi Library 
